Emergent BioSolutions Reports First Quarter 2024 Financial Results
GlobeNewswire
· First Quarter 2024 Total Revenues of $300.4 million, above the prior guidance range
· First Quarter 2024 Net Income of..
· First Quarter 2024 Total Revenues of $300.4 million, above the prior guidance range
· First Quarter 2024 Net Income of..
GAITHERSBURG, Md., Feb. 15, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) today announced that it has entered into an..
Relay by https://truthparadigm.tv